BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arnulf I, Leu-semenescu S, Dodet P. Precision Medicine for Idiopathic Hypersomnia. Sleep Medicine Clinics 2019;14:333-50. [DOI: 10.1016/j.jsmc.2019.05.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Ren R, Yang L, Zhang H, Shi Y, Vitiello MV, Tang X, Sanford LD. Comparative polysomnography parameters between narcolepsy type 1/type 2 and idiopathic hypersomnia: A systematic review and meta-analysis. Sleep Medicine Reviews 2022. [DOI: 10.1016/j.smrv.2022.101610] [Reference Citation Analysis]
2 Evangelista E, Rassu AL, Lopez R, Biagioli N, Chenini S, Barateau L, Jaussent I, Dauvilliers Y. Sleep inertia measurement with the psychomotor vigilance task in idiopathic hypersomnia. Sleep 2021:zsab220. [PMID: 34436617 DOI: 10.1093/sleep/zsab220] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Cortese R. Epigenetics of Sleep Disorders: An Emerging Field in Diagnosis and Therapeutics. Diagnostics (Basel) 2021;11:851. [PMID: 34068472 DOI: 10.3390/diagnostics11050851] [Reference Citation Analysis]
4 Dauvilliers Y, Arnulf I, Foldvary-Schaefer N, Morse AM, Šonka K, Thorpy MJ, Mignot E, Chandler P, Parvataneni R, Black J, Sterkel A, Chen D, Skobieranda F, Bogan RK. Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study. Lancet Neurol 2022;21:53-65. [PMID: 34942138 DOI: 10.1016/S1474-4422(21)00368-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
5 Honda M, Kimura S, Sasaki K, Wada M, Ito W. Evaluation of pathological sleepiness by Multiple Sleep Latency Test and 24-hour polysomnography in patients suspected of idiopathic hypersomnia. Psychiatry Clin Neurosci 2021;75:149-51. [PMID: 33448529 DOI: 10.1111/pcn.13196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 August J, Rosen D. Advances and Current Issues in Adolescent Sleep. Curr Pediatr Rep 2020;8:105-14. [DOI: 10.1007/s40124-020-00224-7] [Reference Citation Analysis]
7 Tanida K, Shimada M, Khor S, Toyoda H, Kato K, Kotorii N, Kotorii T, Ariyoshi Y, Kato T, Hiejima H, Ozone M, Uchimura N, Ikegami A, Kume K, Kanbayashi T, Imanishi A, Kamei Y, Hida A, Wada Y, Kuroda K, Miyamoto M, Hirata K, Takami M, Yamada N, Okawa M, Omata N, Kondo H, Kodama T, Inoue Y, Mishima K, Honda M, Tokunaga K, Miyagawa T. Genome-wide association study of idiopathic hypersomnia in a Japanese population. Sleep Biol Rhythms 2022;20:137-48. [DOI: 10.1007/s41105-021-00349-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chabani E, Vionnet MC, Beauté R, Leu-Semenescu S, Dodet P, Arnulf I. Blackout of my nights: Contentless, timeless and selfless report from the night in patients with central hypersomnias. Conscious Cogn 2020;81:102931. [PMID: 32339976 DOI: 10.1016/j.concog.2020.102931] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Nevsimalova S, Susta M, Prihodova I, Horvat EM, Milata M, Sonka K. Idiopathic hypersomnia: a homogeneous or heterogeneous disease? Sleep Med 2021;80:86-91. [PMID: 33588261 DOI: 10.1016/j.sleep.2021.01.031] [Reference Citation Analysis]
10 Schenck CH, Golden EC, Millman RP. Treatment of severe morning sleep inertia with bedtime long-acting bupropion and/or long-acting methylphenidate in a series of 4 patients. J Clin Sleep Med 2021;17:653-7. [PMID: 33179592 DOI: 10.5664/jcsm.8994] [Reference Citation Analysis]
11 Berro LF, Moreira-Junior EDC, Rowlett JK. The dual orexin receptor antagonist almorexant blocks the sleep-disrupting and daytime stimulant effects of methamphetamine in rhesus monkeys. Drug Alcohol Depend 2021;227:108930. [PMID: 34358767 DOI: 10.1016/j.drugalcdep.2021.108930] [Reference Citation Analysis]
12 Rach H, Kilic-huck U, Reynaud E, Hugueny L, Peiffer E, Roy de Belleplaine V, Fuchs F, Bourgin P, Geoffroy PA. The melanopsin-mediated pupil response is reduced in idiopathic hypersomnia with long sleep time. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-13041-3] [Reference Citation Analysis]
13 Stefani A, Högl B. Sleep Disorders in Parkinson Disease. Sleep Med Clin 2021;16:323-34. [PMID: 33985657 DOI: 10.1016/j.jsmc.2021.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Maski KP, Colclasure A, Little E, Steinhart E, Scammell TE, Navidi W, Diniz Behn C. Stability of nocturnal wake and sleep stages defines central nervous system disorders of hypersomnolence. Sleep 2021;44:zsab021. [PMID: 33512510 DOI: 10.1093/sleep/zsab021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Junnarkar G, Allphin C, Profant J, Steininger TL, Chen C, Zomorodi K, Skowronski R, Black J. Development of a lower-sodium oxybate formulation for the treatment of patients with narcolepsy and idiopathic hypersomnia. Expert Opin Drug Discov 2021;:1-11. [PMID: 34818123 DOI: 10.1080/17460441.2022.1999226] [Reference Citation Analysis]